Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Other neoplasm 1Genitourinary 1Endocrine 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Precancerous Conditions 1Lymphoid Interstitial Pneumonia 1

Interventions

Radiotherapy, Intensity-Modulated 2Cisplatin 2Cetuximab 2vandetanib 1Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Immunohistochemistry 1Gene Expression Profiling 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Biopsy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × vandetanib × Other neoplasm × Clear all
NCT01414426 2021-01-14

Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

University of Chicago

Phase 2 Completed
20 enrolled 7 charts
Head & NeckOther neoplasm

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡